Khiron Life Sciences (STU:4KH) OCF Margin %: -148.97% (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Khiron Life Sciences OCF Margin %?

Khiron Life Sciences STU:4KH OCF Margin % is -148.97% as of Sep. 2022.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Khiron Life Sciences's Cash Flow from Operations for the three months ended in Sep. 2022 was €-3.82 Mil. Khiron Life Sciences's Revenue for the three months ended in Sep. 2022 was €2.56 Mil. Therefore, Khiron Life Sciences's OCF Margin % for the quarter that ended in Sep. 2022 was -148.97%.

As of today, Khiron Life Sciences's current OCF Yield % is 0.00%.

The historical rank and industry rank for Khiron Life Sciences's OCF Margin % or its related term are showing as below:

STU:4KH' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -92.88

STU:4KH's OCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 10.035 vs STU:4KH: -92.88

Khiron Life Sciences OCF Margin % Related Terms

Khiron Life Sciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for Khiron Life Sciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Khiron Life Sciences OCF Margin % Chart

Khiron Life Sciences Annual Data
Trend May12 May13 May14 May15 May16 May17 Dec18 Dec19 Dec20 Dec21
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -1,654.97 -313.85 -306.01 -159.43

Khiron Life Sciences Quarterly Data
Nov17 Feb18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -137.87 -142.08 -60.36 -44.72 -148.97

STU:4KH vs ZTS, CTLT, VTRS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Khiron Life Sciences's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Khiron Life Sciences OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Khiron Life Sciences's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Khiron Life Sciences's OCF Margin % falls into.


Khiron Life Sciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Khiron Life Sciences's OCF Margin for the fiscal year that ended in Dec. 2021 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-14.105/8.847
=-159.43 %

Khiron Life Sciences's OCF Margin for the quarter that ended in Sep. 2022 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-3.818/2.563
=-148.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -148.97% mean?
Khiron Life Sciences (STU:4KH) has a OCF Margin % of -148.97% as of Sep. 2022. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Khiron Life Sciences and its competitors.
Is Khiron Life Sciences' OCF Margin % too high?
Khiron Life Sciences' current OCF Margin % is -148.97%.
How does Khiron Life Sciences' OCF Margin % compare to ZTS and CTLT?
Khiron Life Sciences' OCF Margin % of -148.97% can be compared against companies in the Drug Manufacturers industry. The industry median OCF Margin % is 10.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Khiron Life Sciences and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Khiron Life Sciences's current OCF Margin % is -148.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Khiron Life Sciences stock overvalued right now?
Khiron Life Sciences (STU:4KH) has a current OCF Margin % of -148.97%. The current OCF Margin % is -148.97%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Khiron Life Sciences (STU:4KH), the current OCF Margin % is -148.97% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Khiron Life Sciences Business Description

Address 2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5
Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.